Meriam Kabbaj
Direttore Tecnico/Scientifico/R&S presso GENFIT
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Vincent Forster | M | - |
Versantis AG
 Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | 9 anni |
| Jean-François Mouney | M | 68 | 25 anni | |
| Stefanie Magner | F | 43 | 8 anni | |
| Xavier Guille des Buttes | M | 82 | 18 anni | |
| Laurent Lannoo | M | 54 | 16 anni | |
| Jean-François Tiné | M | 67 | 3 anni | |
| Pascal Caisey | M | 56 | 5 anni | |
| Eric Baclet | M | 64 | 4 anni | |
| Pascal Prigent | M | 56 | 6 anni | |
| Katherine Kalin | F | 61 | 4 anni | |
| Jean-Christophe Marcoux | M | 47 | 9 anni | |
| Anne-Hélène Monsellato | F | 56 | 7 anni | |
| Mark J. Fitzpatrick | M | 61 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Catherine Larue | M | 68 | 7 anni | |
| Dean Hum | M | 61 | 24 anni | |
| Florence Séjourné | F | 52 | 25 anni | |
| Christopher R. Seaton | M | - |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Michael Sidler | M | 55 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Carol L. Addy | M | 64 | 5 anni | |
| Peter Nicklin | M | 61 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Robert Schier | M | - |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
| Thomas Baetz | M | 50 | 3 anni | |
| John Brozek | M | 47 | - | |
| Émilie Desodt | F | 41 | 6 anni | |
| Stephanie Boyer | F | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jean-Christophe Leroux | M | - |
Versantis AG
Versantis AG BiotechnologyHealth Technology Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland. | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Francia | 19 | 73.08% |
| Svizzera | 7 | 26.92% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Meriam Kabbaj
- Contatti personali
